CM

Chhaya Mitesh Mehta

Director Director DIN 00765234
DIN 00765234 First appointment Oct 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Oct 2008
Shareholding value β€’β€’β€’β€’ Premium profile

About Chhaya Mitesh Mehta

Data last updated:

Chhaya Mitesh Mehta has 18 years in corporate governance. Formerly with 1 company, such as S. Parikh Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00765234
Primary Designation Director
First Appointment 10 Oct 2008
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
S. Parikh Pharma Private Limited U74999MH2008PTC187415
Director10 Oct 20082008₹166 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
S. Parikh Pharma Private Limited
Premium access

Shareholding and investment profile for Chhaya Mitesh Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chhaya Mitesh Mehta

Chhaya Mitesh Mehta has 18 years in corporate governance. Formerly with 1 company, such as S. Parikh Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Chhaya Mitesh Mehta has expertise in General Business.

Chhaya Mitesh Mehta has 18 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available